News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,976 Results
Type
Article (13652)
Company Profile (100)
Press Release (249224)
Section
Business (87977)
Career Advice (464)
Deals (15335)
Drug Delivery (64)
Drug Development (36557)
Employer Resources (49)
FDA (6271)
Job Trends (6189)
News (150095)
Policy (14017)
Tag
Academia (435)
Alliances (23178)
Alzheimer's disease (371)
Approvals (6281)
Artificial intelligence (79)
Bankruptcy (144)
Best Places to Work (4358)
Breast cancer (65)
Cancer (457)
Cardiovascular disease (47)
Career advice (406)
Cell therapy (63)
Clinical research (30647)
Collaboration (243)
Compensation (97)
COVID-19 (752)
C-suite (78)
Data (456)
Diabetes (64)
Diagnostics (1251)
Drug discovery (45)
Drug pricing (59)
Earnings (31644)
Events (37025)
Executive appointments (276)
FDA (6544)
Funding (157)
Gene therapy (73)
GLP-1 (314)
Government (1274)
Healthcare (3543)
Infectious disease (774)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5851)
Job creations (2050)
Job search strategy (372)
Layoffs (170)
Legal (3420)
Lung cancer (65)
Manufacturing (115)
Medical device (1266)
Medtech (1268)
Mergers & acquisitions (9591)
Metabolic disorders (200)
Neuroscience (500)
NextGen: Class of 2025 (1581)
Non-profit (591)
Northern California (556)
Obesity (119)
Opinion (113)
Patents (71)
People (28667)
Pharmaceutical (63)
Phase I (7980)
Phase II (12957)
Phase III (11639)
Pipeline (235)
Policy (48)
Postmarket research (1401)
Preclinical (3181)
Radiopharmaceuticals (117)
Rare diseases (121)
Real estate (2631)
Regulatory (9939)
Research institute (563)
Resumes & cover letters (55)
Southern California (544)
Startups (1625)
United States (5429)
Vaccines (124)
Weight loss (86)
Date
Today (42)
Last 7 days (241)
Last 30 days (860)
Last 365 days (12375)
2025 (835)
2024 (12499)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (46)
Asia (19945)
Australia (2581)
California (1308)
Canada (727)
China (172)
Colorado (52)
Connecticut (53)
Europe (39044)
Florida (222)
Illinois (148)
Indiana (105)
Japan (60)
Kansas (53)
Maryland (192)
Massachusetts (1122)
Minnesota (71)
New Jersey (542)
New York (367)
North Carolina (319)
Northern California (556)
Pennsylvania (338)
South America (500)
Southern California (544)
Texas (171)
Virginia (50)
Washington State (86)
262,976 Results for "hedgepath pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Business
W. Mark Watson Elected as Chairman of the Board of HedgePath Pharmaceuticals
HedgePath Pharmaceuticals, Inc. announced that HedgePath’s Board of Directors has elected W. Mark Watson, CPA as Chairman of the Board, effective April 15, 2019.
April 15, 2019
·
4 min read
Press Releases
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
January 27, 2025
·
1 min read
Press Releases
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
January 14, 2025
·
6 min read
Press Releases
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
January 22, 2025
·
2 min read
Press Releases
Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee
December 18, 2024
·
3 min read
Business
HedgePath Pharmaceuticals Announces Name Change to INHIBITOR Therapeutics, Inc. and Ticker Symbol Change to “INTI” Effective August 20, 2019
HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI), today announced plans to change its name to INHIBITOR Therapeutics as well as a change to the ticker symbol for common and preferred stock to “INTI” from “HPPI.”
August 19, 2019
·
6 min read
Press Releases
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
January 23, 2025
·
5 min read
Policy
HedgePath Pharmaceuticals Announces Notice of Allowability of U.S. Patent Application Regarding Treatment of Prostate Cancer
Patent expected to issue coincident with HedgePath’s 2019 efforts to clear IND for SUBA®-Itraconazole for the treatment of prostate cancer
May 6, 2019
·
5 min read
Press Releases
InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds
January 22, 2025
·
5 min read
1 of 26,298
Next
